These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27476291)

  • 41. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate drug release from solid oral dosage forms.
    Schreiner T; Schaefer UF; Loth H
    J Pharm Sci; 2005 Jan; 94(1):120-33. PubMed ID: 15761936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of alginate-based aerogel for nonsteroidal anti-inflammatory drugs controlled delivery systems using prilling and supercritical-assisted drying.
    Gaudio PD; Auriemma G; Mencherini T; Porta GD; Reverchon E; Aquino RP
    J Pharm Sci; 2013 Jan; 102(1):185-94. PubMed ID: 23150457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of the release test method for the topical application of pharmaceutical preparations: release test of cataplasm including nonsteroidal anti-inflammatory drugs using artificial sweat.
    Shimamura T; Tairabune T; Kogo T; Ueda H; Numajiri S; Kobayashi D; Morimoto Y
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):167-71. PubMed ID: 14757999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design of a 24-hour controlled porosity osmotic pump system containing PVP: formulation variables.
    Yakubu R; Peh KK; Tan YT
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1430-8. PubMed ID: 19929202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets.
    Huanbutta K; Sriamornsak P; Limmatvapirat S; Luangtana-anan M; Yoshihashi Y; Yonemochi E; Terada K; Nunthanid J
    Eur J Pharm Biopharm; 2011 Feb; 77(2):320-6. PubMed ID: 21129484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets.
    Garcia-Arieta A; Gordon J; Gwaza L; Mangas-Sanjuan V; Álvarez C; Torrado JJ
    Mol Pharm; 2015 Sep; 12(9):3194-201. PubMed ID: 26237401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation development and statistical optimization of chronotherapeutic tablets of indometacin.
    Tinny T; Chacko AJ; Jose S
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1357-63. PubMed ID: 22931205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Eur J Pharm Biopharm; 2004 Jul; 58(1):51-9. PubMed ID: 15207537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of mefenamic acid sustained release beads based on kappa-carrageenan.
    Ozsoy Y; Bergişadi N
    Boll Chim Farm; 2000; 139(3):120-3. PubMed ID: 10961021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Le Brun V; Wagner T
    Int J Pharm; 2005 Aug; 299(1-2):84-91. PubMed ID: 15970409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design.
    Furlanetto S; Cirri M; Maestrelli F; Corti G; Mura P
    Eur J Pharm Biopharm; 2006 Jan; 62(1):77-84. PubMed ID: 16154333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.
    Hamza Yel-S; Aburahma MH
    Pharm Dev Technol; 2010; 15(2):139-53. PubMed ID: 19895367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of new topical ketoprofen formulations prepared by drug entrapment in solid lipid matrices.
    Argemí A; Domingo C; de Sousa AR; Duarte CM; García-González CA; Saurina J
    J Pharm Sci; 2011 Nov; 100(11):4783-9. PubMed ID: 21710507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of poly(acrylic acid) superporous hydrogel microparticles as a super-disintegrant in fast-disintegrating tablets.
    Yang S; Fu Y; Jeong SH; Park K
    J Pharm Pharmacol; 2004 Apr; 56(4):429-36. PubMed ID: 15099437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.